Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 14, 2023; 29(18): 2836-2849
Published online May 14, 2023. doi: 10.3748/wjg.v29.i18.2836
Table 4 The risk factors are related to tumor budding

BD1
BD2
BD3
No budding
r
P value
Infiltrative depth, %0.669< 0.001
M0 (0.0)3 (21.4)0 (0.0)14 (70.0)
SMp10 (83.3)1 (7.1)3 (17.6)
SMd2 (16.7)10 (71.4)14 (82.4)
Lymphovascular invasion0.663< 0.001
Yes2 (28.6)4 (21.1)16 (94.1)1 (5.0)
No5 (71.4)15 (78.9)1 (5.9)19 (95.0)
Lymph node metastasis0.489< -0.001
Yes1 (14.3)1 (5.3)9 (52.9)0 (0.0)
No6 (85.7)18 (94.7)8 (41.7)20 (100.0)
Perineural infiltration0.601< 0.001
Yes2 (28.6)4 (21.1)13 (76.5)0 (0.0)
No5 (71.4)15 (78.9)4 (23.5)20 (100.0)
Tumor infiltrating lymphocytes0.476< 0.001
Yes7 (100.0)19 (100.0)14 (82.4)6 (30.0)
No0 (0.0)0 (0.0)3 (17.6)14 (70.0)
Differential degree0.706< 0.001
G10 (0.0)0 (0.0)0 (0.0)19 (95.0)
G1-22 (28.6)9 (47.4)7 (41.2)0 (0.0)
G25 (71.4)10 (52.6)4 (23.5)1 (5.0)
G3-20 (0.0)0 (0.0)6 (35.3)0 (0.0)